Dalian Asia Space Pharmaceutical [Dalian] Inc is a joint venture founded by Dalian Tianwei Pharmaceutical Co., Ltd. and YES Biotechnological Research Co., Ltd. Canada, specializing in researching and manufacturing monoclonal antibody researching and Space built up a 2,600m² monoclonal antibody researching and manufacturing system and SPF-level animal facility according to the requirements of national GMP and the design of ATCC of the US. Its equipment and technology has reached world top level. The company successfully developed and invented Abcream (Anti-Interleukin-8 Monoclonal Antibody Cream) that was the first innovation drug in the world against psoriasis with international intellectual property right. Asia Space pioneered the application of monoclonal antibody, and became the first industrialized production base of “Bio-missile” in China.

大连天维药业股份有限公司位于大连双D港生物制药园。公司已全面通过药品、保健食品GMP认证，可生产片剂、颗粒剂、胶囊剂、散剂等剂型的药品和保健食品。大连天维药业股份有限公司以生物制药和中药现代化研发为产业方向，以生产生物药品、中药和保健食品为产业基础，以面向国内、国际市场，打造中国优秀的生物药品、中药和保健食品品牌为产业发展目标，秉承“诚信为人、诚信制药、诚信人类健康”的企业宗旨，向着国际化的发展目标迈进。

Dalian Tianwei Pharmaceutical Co., Ltd. is one of the first hi-tech enterprises settled down in Dalian D-D Port. In 2004, it got GMP approved, and its products are drugs and health foods made in tablets, graduals, capsules and powder. Tianwei focuses on the research and development of bio-pharmacy and Chinese traditional medicine, based on the developing of biomedicine, Chinese traditional medicine and health foods, aiming to fame its brand in both Chinese and overseas market.

• 加拿大YES生物技术研究有限公司（YES Biotechnological Research Co., Ltd. Canada）

加拿大YES生物技术研究有限公司是北美地区第一个由来自中国大陆的科学家创建和主持的生物医学高科技公司。十五年来，YES公司在叶庆炜博士领导下长期致力于单克隆抗体产品的研发和应用，在国际上最早提出“抗趋化因子治疗”的观点，应用于临床疑难病症的治疗。YES公司拥有自主知识产权的各种单克隆抗体达280余个克隆，是北美地区最大的“生物导弹”库之一，单克隆抗体的品种和数量名列加拿大首位，是加拿大14个重点生物技术公司之一。YES公司拥有世界先进水平的研究和生产设置，是世界上第三个通过ISO 9001 和 ISO 13485认证的单克隆抗体技术公司，具有现代化严格管理和运作体系的高科技企业。

YES Biotechnological Research Co., Ltd. Canada is the first hi-tech biomedical company founded by Chinese scientists in North America. Under the leadership of Dr. Ye Qingwei over the past 15years, YES Corp. has been engaged in the research, development and application of monoclonal antibody (“Bio-missile”) products. It took the lead in giving the opinion of “anti-chemotactic factor treatment” and appling it to clinical difficult and complicated cases in the world. YES Corp. has intellectual property rights to its more than 280 monoclonal antibodies. As one of the biggest “Bio-missile” warehouses in North America and one of 14 key biotechnology companies in Canada, YES Corp. ranks the first in Canada in both of variety and quantity of monoclonal antibodies. With great research findings, advanced production equipment, modern strict system of management and operation, it is the third monoclonal antibody hi-tech enterprise in the world that got ISO 9001 and ISO 13485 approved.

【关联企业】

上海亚联抗体医药有限公司（Shanghai Asia United Antibody Medical Co., Ltd.）

2002年11月，加拿大YES生物技术研究有限公司和上海科技投资公司、浦东科技投资有限公司三方合资在浦东张江高科技园区建立了上海亚联抗体医药有限公司，总投资1亿元人民币。上海亚联抗体医药有限公司拥有1500平方米单克隆抗体药物中试规模GMP设置，拥有15立升和110立升的生物反应器6台，大型单克隆抗体纯化系统两套，先进的抗体药物筛选系统一套，以及国际领先水平的人源化抗体高表达系统。大连亚维与上海亚联紧密合作，力争成为国际、国内第一流的单克隆抗体药物研发和中试生产企业。